S. Harder
- Geriatrics and Gerontology top 5%
- Internal Medicine top 5%
- Pharmaceutical Science top 5%
- Pharmacology top 5%
- Transplantation top 10%
-
- Pharmaceutical studies and practices 13
- Pharmacological Effects and Toxicity Studies 6
-
- Antiplatelet Therapy and Cardiovascular Diseases 8
- Atrial Fibrillation Management and Outcomes 6
-
- Analytical Methods in Pharmaceuticals 7
-
- Drug Transport and Resistance Mechanisms 7
-
- Parkinson's Disease Mechanisms and Treatments 6
-
- Platelet Disorders and Treatments 6
- Co-authors
- A. H. StaibJochen GraffUwe FuhrPetra ThürmannStephan RietbrockH. BaasUte KlinkhardtW. Stille
- Journals
- European Journal of Clinical Pharmacology (8 papers)Clinical Pharmacology & Therapeutics (4 papers)British Journal of Clinical Pharmacology (4 papers)
- Partner nations
- GermanyUnited StatesCzechia
In The Last Decade
S. Harder
70 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 110
- Geriatrics and Gerontology 77
- Internal Medicine 71
- Pharmaceutical Science 114
- Pharmacology 133
- Transplantation 38
Countries citing papers authored by S. Harder
This map shows the geographic impact of S. Harder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Harder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Harder more than expected).
Fields of papers citing papers by S. Harder
This network shows the impact of papers produced by S. Harder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Harder. The network helps show where S. Harder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. Harder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 75 | |
| 2 | 2009 | 0 | |
| 3 | 2008 | 26 | |
| 4 | 2007 | 17 | |
| 5 | 2007 | 45 | |
| 6 | 2007 | 7 | |
| 7 | 2005 | 8 | |
| 8 | 2005 | 61 | |
| 9 | 2004 | 19 | |
| 10 | 2002 | 46 | |
| 11 | 2002 | 26 | |
| 12 | 2001 | 4 | |
| 13 | 2001 | 3 | |
| 14 | 2000 | 37 | |
| 15 | 2000 | 29 | |
| 16 | 1999 | 69 | |
| 17 | 1997 | 45 | |
| 18 | 1993 | 4 | |
| 19 | Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid. | 1989 | 20 |
| 20 | 1987 | 28 |
About S. Harder
S. Harder is a scholar working on Family Practice, Internal Medicine, Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 73 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Analytical Methods in Pharmaceuticals (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Atrial Fibrillation Management and Outcomes (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers), Platelet Disorders and Treatments (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). The work is most often cited by research in Geriatrics and Gerontology (77 citations), Internal Medicine (71 citations), Pharmaceutical Science (114 citations), Pharmacology (133 citations) and Transplantation (38 citations). S. Harder has collaborated with scholars based in Germany, United States and Czechia. Frequent co-authors include A. H. Staib, Jochen Graff, Uwe Fuhr, Petra Thürmann, Stephan Rietbrock, H. Baas, Ute Klinkhardt, W. Stille, P. M. Shah and D. Beermann. Their work appears in journals such as European Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, Journal of Antimicrobial Chemotherapy and JDDG Journal der Deutschen Dermatologischen Gesellschaft.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.